Structure Therapeutics (GPCR) Shares Issued (2022 - 2026)

Structure Therapeutics' Shares Issued history runs 5 years deep, the most recent figure standing at $869000.0 for Q1 2026.

• In Q1 2026, Shares Issued fell 9.95% year-over-year to $869000.0; the TTM figure through Mar 2026 stood at $60.6 million (up 2836.92% YoY), while the FY2025 annual figure was $4.5 million, up 144.07% from the prior year.
• Shares Issued was $869000.0 for Q1 2026 at Structure Therapeutics, down from $3.1 million in the prior quarter.
• In the past five years, Shares Issued ranged from a high of $513.8 million in Q2 2024 to a low of -$512.9 million in Q3 2024.
• Historically, Shares Issued has averaged $26.0 million across 5 years, with a median of $812000.0 in 2024.
• The sharpest annual moves came in 2023 and 2024: Shares Issued surged 1531.03% in 2023, then slumped 108544.61% in 2024.
• A 5-year view of Shares Issued shows it stood at $29000.0 in 2022, then surged by 1032027.59% to $299.3 million in 2023, then plunged by 99.93% to $224000.0 in 2024, then surged by 1301.79% to $3.1 million in 2025, then sank by 72.32% to $869000.0 in 2026.
• The last three Shares Issued figures came in at $869000.0 (Q1 2026), $3.1 million (Q4 2025), and $57.1 million (Q3 2025), per Business Quant data.